New Migraine Medication 2025. The fda initially approved rimegepant (nurtec odt) for acute use—to treat an. Since 2018, several new therapies to both treat migraine and/or prevent migraine attacks have become newly available.

Most of the time, it’s best to take them as soon as you notice symptoms. The fda is reviewing the new drug application resubmission with a decision expected by january 31, 2025.